Clinical Trial Update: (Cost-)Effectiveness of SLIMMER Diabetes Prevention Intervention [NA]

View source ↗

Summary

An update on the cost-effectiveness evaluation of the SLIMMER diabetes prevention intervention. The trial focuses on Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Wageningen University | Conditions: Diabetes Mellitus Type 2 | NA | Status: UNKNOWN